214 related articles for article (PubMed ID: 28811537)
21. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
Yang YP; Qing HY; Cao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):31-4. PubMed ID: 12760773
[TBL] [Abstract][Full Text] [Related]
23. Survival and patterns of relapse in patients with oral tongue cancer.
Rusthoven KE; Raben D; Song JI; Kane M; Altoos TA; Chen C
J Oral Maxillofac Surg; 2010 Mar; 68(3):584-9. PubMed ID: 19939533
[TBL] [Abstract][Full Text] [Related]
24. Importance of tumor budding grade as independent prognostic factor for early tongue squamous cell carcinoma.
Ebihara Y; Yoshida S; Nakahira M; Kogashiwa Y; Enoki Y; Kuba K; Inoue H; Minami K; Yasuda M; Sugasawa M
Head Neck; 2019 Jun; 41(6):1809-1815. PubMed ID: 30633412
[TBL] [Abstract][Full Text] [Related]
25. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
26. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.
de Vicente JC; Peña I; Rodrigo JP; Rodríguez-Santamarta T; Lequerica-Fernández P; Suárez-Fernández L; Allonca E; García-Pedrero JM
Head Neck; 2017 Sep; 39(9):1876-1887. PubMed ID: 28675642
[TBL] [Abstract][Full Text] [Related]
28. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
[TBL] [Abstract][Full Text] [Related]
29. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
31. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.
Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Warnakulasuriya S; Lopes C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):638-45. PubMed ID: 23601218
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
34. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.
Almangush A; Bello IO; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Nieminen O; Soini Y; Kosma VM; Koivunen P; Grénman R; Leivo I; Salo T
Head Neck; 2014 Jun; 36(6):811-8. PubMed ID: 23696499
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer.
Dhillon T; Mauri FA; Bellezza G; Cagini L; Barbareschi M; North BV; Seckl MJ
J Thorac Oncol; 2010 Mar; 5(3):314-9. PubMed ID: 20093977
[TBL] [Abstract][Full Text] [Related]
36. Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival.
Noi M; Mukaisho KI; Murakami S; Koshinuma S; Machida Y; Yamori M; Nakayama T; Ogawa T; Nakata Y; Shimizu T; Yamamoto G; Sugihara H
Clin Exp Dent Res; 2020 Aug; 6(4):420-427. PubMed ID: 32281236
[TBL] [Abstract][Full Text] [Related]
37. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Ernst J; Ikenberg K; Apel B; Schumann DM; Huber G; Studer G; Rordorf T; Riesterer O; Rössle M; Korol D; Bredell MG
Oncotarget; 2016 Nov; 7(46):76151-76158. PubMed ID: 27764819
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer.
Li H; Zhang Y; Chen SW; Li FJ; Zhuang SM; Wang LP; Zhang J; Song M
Int J Clin Exp Pathol; 2014; 7(3):996-1003. PubMed ID: 24695539
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.
Naruse T; Yanamoto S; Yamada S; Rokutanda S; Kawakita A; Kawasaki G; Umeda M
Pathol Oncol Res; 2015 Jul; 21(3):765-73. PubMed ID: 25682238
[TBL] [Abstract][Full Text] [Related]
40. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
Li SH; Lin WC; Huang TL; Chen CH; Chiu TJ; Fang FM; Huang WT; Hsu CM; Luo SD; Lai CC; Su YY; Chuang HC; Chien CY
Head Neck; 2016 Apr; 38 Suppl 1():E844-52. PubMed ID: 25917382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
